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Introduction {#sec1}
============

According to the prevailing model, organogenesis is initiated with the specification of a subset of cells as progenitors that are then organized to form a primordium. As development proceeds, the primordium undergoes extensive growth, differentiation, and morphogenesis until the organ obtains its final form ([@bib1], [@bib6]; Göttgens, 2013; [@bib7], [@bib19], [@bib35], [@bib39]). Synovial joints are structures that separate adjacent skeletal elements and thus allow locomotion. The mature joint is composed of articular cartilage, synovial fluid, ligaments, and a fibrous capsule, which together function to transmit biomechanical loads during skeletal motion ([@bib4]).

The first histological indication for joint formation is the appearance of a higher cell density domain called the interzone at the site of the future joint. The interzone consists of three layers, the middle of which is termed the intermediate zone ([@bib23]). Molecularly, interzone cells lose the expression of chondrocyte-specific genes such as collagen type II. Instead, they express a new set of genes that includes growth and differentiation factor 5 (*Gdf5*), *Wnt4*, and *Wnt9a* ([@bib8], [@bib10], [@bib34], [@bib37]).

Over the years, it has been suggested that interzone cells serve as joint progenitors. Removal of the interzone was shown to lead to joint loss and bone fusion ([@bib11]). Light and electron microscopy studies have suggested that interzone cells from the two outside layers contribute secondarily to the adjacent epiphyses, whereas intermediate zone cells form the external layers of the joint ([@bib14]). Finally, lineage studies utilizing *Gdf5*-*Cre* mice showed that cells of all mature joint components originate from *Gdf5*-expressing lineages, further promoting the view that interzone cells are joint progenitors ([@bib17], [@bib18], [@bib29]).

These works support a model in which, during the initial stages of skeletogenesis, a subset of mesenchymal cells is specified as interzone cells to serve as joint progenitors. However, evidence accumulated in recent years indicates that, during development, cells from the vicinity are integrated into the forming joint ([@bib13], [@bib17], [@bib25], [@bib28]). These findings suggest a more elaborate mode of development, reopening the question of whether joint development follows the widely accepted scheme of organogenesis. In this study, we use a new *Gdf5-CreER*^T2^ knockin mouse line to propose a revised model for joint development. We show that joint development occurs through a continuous influx of new cells that are integrated into the interzone, where they contribute to the forming joint, hence the term influx model. Finally, we show that this mechanism facilitates lineage divergence and, thereby, joint development.

Results {#sec2}
=======

Establishment of the *Gdf5-CreER* Knockin Mouse as a Model System {#sec2.1}
-----------------------------------------------------------------

The current consensus that *Gdf5*-positive interzone cells are joint progenitors has been based on lineage tracing experiments using a *Gdf5-Cre* transgenic mouse. This line was produced by integrating the Cre recombinase sequence into a 140-kb bacterial artificial chromosome (BAC) containing the *Gdf5* locus ([@bib29]). This transgene might not contain all of the potential regulatory elements that control endogenous *Gdf5* expression and might also be influenced by the genomic integration site. Therefore, to directly test that view, we sought to generate a *Gdf5-CreER* mouse that would allow us to temporally label *Gdf5*-expressing cells. Taking a knockin approach, we inserted a cassette encoding for *CreER* into the translation start site of the *Gdf5* gene using homologous recombination ([Figure S1](#mmc1){ref-type="supplementary-material"}Aa). To demonstrate both the accuracy and the efficiency of the new *Gdf5-CreER* line, we crossed this mouse with a *Rosa26-tdTomato* reporter line and induced recombination by a single tamoxifen dose administered on embryonic day (E) 13.5. Whole-mount preparations of E18.5 embryos showed that joints in the vertebrae, forelimb, and hindlimb were marked ([Figures S1](#mmc1){ref-type="supplementary-material"}Ab--S1Ad''), suggesting that Cre recombinase activity was indeed restricted to joints. Importantly, no reporter activity was evident without tamoxifen administration ([Figures S1](#mmc1){ref-type="supplementary-material"}Ba--S1Bc).

Next, we crossed mice heterozygous for *Gdf5-CreER* and analyzed the homozygous offspring. As expected, the phenotype recapitulated that of *brachypodism (bp)* mice ([@bib9], [@bib22], [@bib37]); namely, malformation in the autopods and fibula, failure of cruciate ligament development, and expansion of the *Gdf5* expression domain in the autopod ([Figures S1](#mmc1){ref-type="supplementary-material"}Ca--S1Ce'). Together, these results indicate that the *Gdf5-CreER* line is a suitable system for lineage analysis of *Gdf5*-positive interzone cells.

Joint-Forming Cells Are Not Specified in a Single Early Event {#sec2.2}
-------------------------------------------------------------

According to the interzone progenitor model, once the interzone has formed, the cells inside it are specified as joint progenitors, as indicated by *Gdf5* expression. This hypothesis predicts that administration of tamoxifen at that stage would "capture" most of the population of joint progenitors, resulting in cell labeling throughout the joint. To directly examine this hypothesis, we performed a series of pulse-chase experiments by crossing *Gdf5-CreER* mice with the *Rosa26-tdTomato* reporter. As seen in [Figure 1](#fig1){ref-type="fig"}A, on E11.5, *Gdf5* expression was clearly observed in the presumptive elbow, knee, and autopod joints. Assuming a 24-hr delay in maximum Cre activity, a single dose of tamoxifen was administered on E10.5 to label *Gdf5*-positive interzone cells. Interestingly, analysis of sections through the knee, elbow, and metacarpophalangeal joints on E18.5 showed only restricted labeling, mostly of epiphyseal cells ([Figure 1](#fig1){ref-type="fig"}B). This surprising result suggests that the *Gdf5*-positive cells that populate the interzone at the time of its formation are not the main source of joint progenitors.

An alternative hypothesis that could reconcile our observations with those obtained previously using the *Gdf5-Cre* line is that there is a constant inflow of new cells into the forming joint. The "influx" model predicts that a single administration of tamoxifen will mark only a partial population of joint cells and that only several administrations at different developmental stages will induce extensive labeling. To test this hypothesis, we administered three doses of tamoxifen on E11.5, E13.5, and E15.5. Examination of sections through several E18.5 joints showed that *tdTomato*-positive cells occupied most of the joint area ([Figure 1](#fig1){ref-type="fig"}C), thus reinforcing the influx hypothesis.

The interzone progenitor model implies a requirement for continuous proliferation of the progeny of early-specified *Gdf5*-positive progenitors throughout development to sustain rapid joint growth. To further distinguish between the two hypotheses, we examined the proliferative potential of these cells. We analyzed, by bromodeoxyuridine (BrdU) assay, the descendants of *Gdf5*-positive cells labeled by a single tamoxifen administration on E11.5. Sections through the elbow and knee joints showed that approximately 20% of the descendants, marked by tdTomato, were proliferating on E13.5. Moreover, the level of proliferation dramatically decreased through E15.5 and E18.5 ([Figures 1](#fig1){ref-type="fig"}D and 1E). Taken together, these results imply a continuous influx of cells into the forming joint.

Joint Development Involves a Continuous Influx of New *Gdf5*-Expressing Cells {#sec2.3}
-----------------------------------------------------------------------------

Next, to directly demonstrate the recruitment process, we monitored the spatial distribution of *Gdf5* and *tdTomato* expression in the interzone during development. The probe for the *tdTomato* gene was expected to mark cells that have already been specified as *Gdf5*-positive at the time of tamoxifen administration and their descendants, whereas the probe for *Gdf5* would mark cells that expressed *Gdf5* at the time of harvesting. Thus, expression of both markers would indicate cells that were recruited early and maintained *Gdf5* expression, whereas newly recruited, non-pulsed cells would express only *Gdf5*. First, to verify the sensitivity of in situ hybridization (ISH) for *tdTomato*, we compared the results of that assay (red) with immunofluorescent staining for tdTomato protein (green) ([Figure 2](#fig2){ref-type="fig"}A). The co-localization of labeled cells showed that ISH for *tdTomato* is a reliable tool in cell lineage studies.

According to our model, immediately after Cre activation, interzone cells should express both *Gdf5* and *tdTomato.* To examine this assumption, we performed double ISH for both genes on sections from *Gdf5-CreER*, *Rosa26-tdTomato* embryos following administration of a single dose of tamoxifen at different time points during joint development (E11.5--E13.5). Embryos were harvested 28 hr after tamoxifen administration because we had expected a delayed activation of the Rosa26 reporter. In agreement with our hypothesis, sections through the knee showed a high overlap between *Gdf5*- and *tdTomato*-positive cells pulsed at all the time points ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}).

To assess the efficiency of *Gdf5-CreER* recombination quantitatively, we measured the level of co-localization of *Gdf5*- and *tdTomato*-expressing cells. The results showed that 60%--67% of the *Gdf5* expression domain was also positive for *tdTomato* ([Figure 2](#fig2){ref-type="fig"}C). Surprisingly, 28 hr after tamoxifen administration, we already observed a population of *tdTomato*-positive, *Gdf5*-negative cells ([Figure 2](#fig2){ref-type="fig"}B, arrows). Assessment of the proportion of that population relative to the entire *tdTomato* expression domain showed that, at all examined stages, approximately 30% of *tdTomato*-positive cells had already lost *Gdf5* expression. This observation indicates a very dynamic cellular behavior and suggests that the actual recombination efficiency is higher than calculated ([Figures 2](#fig2){ref-type="fig"}C and 2D). Moreover, the coexpression of *Gdf5* and *tdTomato* by most cells after that interval demonstrated our ability to effectively detect the expression of both markers as well as the high level of Cre activity following a single tamoxifen administration.

Another prediction of our model is that longer pulse-chase intervals would reduce the overlap between the *Gdf5* and *tdTomato* expression domains as a result of *Gdf5* expression by cells recruited after pulsing. Indeed, examination of E13.5--E15.5 knee joints of embryos pulsed on E11.5 showed that, in addition to cells that co-expressed both markers, a high number of cells expressed only *Gdf5* but not *tdTomato* ([Figure 2](#fig2){ref-type="fig"}E, arrows). As in the previous experiment ([Figure 2](#fig2){ref-type="fig"}B), a third population of cells that solely expressed *tdTomato* was also identified, presumably having lost *Gdf5* expression. These results reveal a highly dynamic behavior of joint-forming cells; new cells turn *Gdf5* expression on, whereas others turn it off.

Because, in that experiment, tamoxifen was administered only on E11.5, the observed dynamic behavior could be unique to that developmental stage. To address that issue, we repeated the pulse-chase experiments, administering single doses of tamoxifen at different stages (E10.5--E13.5), and examined *tdTomato* and *Gdf5* expression in the knee joint on E15.5. In all experiments, the three abovementioned populations were detected ([Figure 2](#fig2){ref-type="fig"}F), indicating a continuous influx of *Gdf5*-positive cells into the joint.

Finally, our finding that cells were constantly leaving the *Gdf5* expression domain suggested that the contribution of the *Gdf5* lineage to the developing epiphyses is more intricate and fine-tuned than has been appreciated previously ([@bib17], [@bib29], [@bib36]). To better understand the temporal contribution of the *Gdf5* lineage to the epiphysis, we performed pulse-chase experiments using *Gdf5-CreER* mice crossed with *Rosa26-tdTomato* mice. Following administration of a single dose of tamoxifen on E11.5--E13.5, E15.5 embryos were stained for both tdTomato and collagen type II α 1 (COL2A1). Activation on E11.5 resulted in a substantial population of tdTomato, COL2A1 double-positive cells. Later marking of *Gdf5*-expressing populations by tamoxifen administration on E12.5--E13.5 ([Figure 2](#fig2){ref-type="fig"}G) resulted in a gradual decrease in labeling of epiphyseal chondrocytes and labeled chondrocytes more proximal to the joint, indicating a spatial shift toward the joint area. These results indicate that the cells lost their *Gdf5* expression ([Figure 2](#fig2){ref-type="fig"}F), joined the growing cartilage, and differentiated into chondrocytes ([Figure 2](#fig2){ref-type="fig"}G).

This set of experiments shows that the *Gdf5* expression domain is highly dynamic, with a constant influx of new cells into the joint area as well as out of it into the epiphyses.

The Influx of Cells into the Joint Facilitates Lineage Divergence {#sec2.4}
-----------------------------------------------------------------

A possible implication of the influx model is that *Gdf5*-positive cells recruited at different time points may give rise to specific joint tissues. To address this hypothesis, we analyzed the spatiotemporal contribution of cell lineages marked at different stages to various joints of E18.5 embryos. For that, we administered single doses of tamoxifen between E10.5 and E16.5 to embryos heterozygous for *Gdf5-CreER* and *Rosa26-tdTomato*. As seen in [Figure 3](#fig3){ref-type="fig"}, descendants of *Gdf5*-positive cells marked at different time points populated different regions of the developing joints.

In the knee, *Gdf5*-positive cells were detected in the epiphyses, articular cartilage, meniscus, and intra-articular ligaments. Early tamoxifen administration (on E10.5) resulted in *tdTomato*-positive cells located mostly at the epiphyses. However, when tamoxifen was administered at E11.5, *tdTomato*-positive cells were also observed in the articular cartilage. Upon activation on E12.5--E13.5, the number of *tdTomato*-positive cells in the epiphyses decreased, whereas their relative number in the articular cartilage increased. Finally, following activation on E14.5--E15.5, the expression was restricted to the most superficial layer of the articular cartilage ([Figures 3](#fig3){ref-type="fig"}A and 3B). Tamoxifen administration at all stages led to a contribution of *tdTomato*-positive cells to the meniscus and intra-articular ligaments. However, whereas pulsing at early and intermediate stages led to a massive contribution throughout the tissues, at later stages it resulted in an exclusive contribution of these cells to the edges of the meniscus ([Figure 3](#fig3){ref-type="fig"}A) and intra-articular ligament ([Figure 3](#fig3){ref-type="fig"}C).

In the elbow joint, a similar trend was observed, except that a contribution of *Gdf5*-positive cells to the articular cartilage was observed following activation on E12.5 ([Figures 3](#fig3){ref-type="fig"}D and 3E). The metacarpophalangeal joint also exhibited a similar spatiotemporal pattern. However, administration on E13.5 ([Figure 3](#fig3){ref-type="fig"}F) resulted in prominent labeling of the joint capsule. Finally, the different contribution of labeled cells to epiphyseal chondrocytes seen in knee sections ([Figures 3](#fig3){ref-type="fig"}A and 3C) prompted us to further examine the spatial distribution of *Gdf5*- and *tdTomato*-expressing cells in E15.5 embryos pulsed on E11.5 ([Figure 3](#fig3){ref-type="fig"}G) or E12.5 ([Figure 3](#fig3){ref-type="fig"}H). Mid-sagittal sections through the knee, where the cruciate ligaments were visualized, revealed significantly more cells that expressed both genes ([Figures 3](#fig3){ref-type="fig"}G and 3H, bottom) and a clear reduction in *tdTomato*-positive, *Gdf5*-negative cells compared with medial sections showing the menisci. Presumably, the latter cell population highly contributes to the epiphysis ([Figures 3](#fig3){ref-type="fig"}G and 3H, top).

Importantly, in all joints we observed asymmetry in the contribution of *Gdf5*-positive cells to the skeletal elements at the two sides of the joint. For example, the femur and the humerus were more extensively marked than the opposing bones. This observation suggests that asymmetric contribution may be part of the morphogenetic process ([Figure 1](#fig1){ref-type="fig"}C).

Overall, the spatiotemporal differences in *Gdf5* expression patterns show the dynamics of the establishment of the different joint tissues. Although some elements, like the cruciate ligaments and menisci, are formed by constant recruitment of new *Gdf5-*expressing cells that maintain its expression, others, like the metacarpophalangeal joint capsule, originate from a temporally specific group of cells. It is tempting to speculate that this mode of development may facilitate lineage divergence into different cell fates to allow the formation of the various tissues that compose the joint.

A Continuous Influx of *Sox9*-Positive Cells May Contribute to Joint Morphogenesis {#sec2.5}
----------------------------------------------------------------------------------

Previously, it was shown that joint cells originate from *Sox9*-positive chondroprogenitor cells ([@bib33]). To confirm this, we crossed *Sox9-CreER* mice with the *Rosa26-tdTomato* reporter. Examination of E15.5 knee and elbow joints following administration of a single tamoxifen dose at E10.5 showed that all structures of the joints were *tdTomato*-positive, thus originating from an early population of *Sox9*-positive cells ([Figures S3](#mmc1){ref-type="supplementary-material"}Aa--S3Ad). To further establish that *Gdf5*-positive cells are derived from that early pool, double ISH for *tdTomato* and *Gdf5* was performed on sections through the knee of *Sox9-CreER*, *Rosa26-tdTomato* heterozygous embryos. The co-expression of both markers confirmed that conclusion ([Figure S3](#mmc1){ref-type="supplementary-material"}Ae).

Several studies have suggested that cells from the vicinity may migrate into the developing joint ([@bib13], [@bib17], [@bib25], [@bib28]). To locate the source that may supply new cells to the developing joint, we next analyzed the expression of the two abovementioned genes alongside COL2A1, a marker of differentiating chondrocytes, throughout joint development. To visualize all three markers simultaneously, double ISH for *Sox9* and *Gdf5* was performed together with immunofluorescence staining for COL2A1. Examination of the elbow and knee joints at E12 revealed, as expected, a population of *Sox9*-*Gdf5* double*-*positive cells at the presumptive joint area. This population was later observed at all examined stages ([Figures 4](#fig4){ref-type="fig"}A--4F and [S3](#mmc1){ref-type="supplementary-material"}Ca--S3Cf). However, around the developing joint, we observed a cloud of *Sox9*-positive cells that did not express *Col2a1* or *Gdf5* ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}Ca). That population was also prominent in double immunofluorescence staining for SOX9 and COL2A1 ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

As development proceeded, two concurrent events were observed: massive growth and morphogenesis of the joint and a gradual reduction in the population of *Sox9*-positive, *Col2a1*, *Gdf5*-negative cells around the joint ([Figures 4](#fig4){ref-type="fig"}A--4F and [S3](#mmc1){ref-type="supplementary-material"}Ca--S3Cf; arrows), which was also confirmed by immunofluorescent staining ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Interestingly, in the interzone, between the *Col2a1*-positive cells that flanked it and the *Gdf5* expression domain, another population of cells that was *Sox9*-positive and *Col2a1, Gdf5*-negative was observed ([Figures 4](#fig4){ref-type="fig"}C, 4D, and [S3](#mmc1){ref-type="supplementary-material"}C; dashed arrows). These cells were likely descendants of early *Gdf5*-positive cells that had lost *Gdf5* expression, as we demonstrated previously ([Figure 2](#fig2){ref-type="fig"}), and were in the process of differentiation to chondrocytes while integrating into the epiphyses ([Figure S3](#mmc1){ref-type="supplementary-material"}D).

Together, these results suggest that *Sox9*-positive, *Col2a1*, *Gdf5*-negative cells from the vicinity of the joint migrate into the forming joint, turn on *Gdf5* expression, and contribute to joint development.

Discussion {#sec3}
==========

Over the years, a general scheme of organogenesis has been widely adopted. This scheme has guided efforts to trace the lineages of organ-forming cells to identify their progenitors. In accordance with this view, *Gdf5*-positive interzone cells have been suggested as joint progenitors. However, the data we present here are inconsistent with the progenitor model sensu stricto and favor an alternative strategy for joint development that involves a constant influx of new cells that are integrated into the forming organ to sustain its development.

Several lines of evidence in our study are inconsistent with the view that joint progenitor cells are all specified at an early stage of limb development. None of our attempts, using a knockin *Gdf5-CreER* line, to capture the entire progenitor population by a single Cre activation succeeded; each time, only a certain subpopulation of joint cells was marked. Only several doses of tamoxifen at different developmental stages resulted in extensive labeling throughout the joint. Moreover, cell proliferation assays revealed a reduction in the proliferation of the *Gdf5* lineage through development that could not accommodate the demands of the developing joint. Finally, our finding of a time-dependent increase in the number of new *Gdf5-*positive cells in the interzone may also be incompatible with the progenitor model.

A possible limitation of our approach would be low recombination activity of the new *Gdf5-CreER* line, which would lead to low labeling efficacy. However, comparable levels of *tdTomato* and endogenous *Gdf5* expression observed and computed shortly after Cre activation suggest that our new line acts efficiently on the *Rosa26-tdTomato* reporter line.

The concept of the addition of cells to a developing organ instead of relying exclusively on proliferation of progenitor cells is interesting. Previously, we showed that cells that form bone eminences and the patella are added secondarily to the already established bone shaft anlage ([@bib2], [@bib3], [@bib5]). Although these studies fall short of providing direct evidence for the continuity of this process, the different timing suggests that the influx model may be a broader phenomenon in skeletal development.

Intriguingly, our findings may appear to disagree with Holder's seminal experiment in which removal of the interzone led to failure in joint development ([@bib11]). There are several possible ways for reconciling these seemingly opposing conclusions. For example, Holder might have removed with the interzone the surrounding tissues, including the potential source for migrating *Gdf5-*positive cells, leading to failure in joint development. Also, several lines of evidence support the notion that the interzone is a vital signaling center in joint development ([@bib4], [@bib20]). Thus, removal of the interzone could have eliminated the regulatory signals mediating the recruitment process. A third possibility is that Holder also removed muscles, which were shown previously by us and others to be essential for joint development ([@bib16], [@bib24], [@bib27], [@bib32]).

A central question in organ development is the mechanism by which lineage divergence occurs to form different tissues. This question is particularly interesting in the case of joint development because all joint tissues were shown to originate from *Gdf5*-expressing cells ([@bib17], [@bib18], [@bib29]). Previous studies have suggested two possible mechanisms for the divergence into epiphyseal and articular chondrocytes based on either temporal or spatial differences. The temporal hypothesis is that cells that express *Gdf5* early will contribute to the epiphysis ([@bib36]), whereas the spatial hypothesis is that the location of the progenitors in the interzone determines the ultimate lineage destination ([@bib14]). We propose the high cellular dynamics of *Gdf5* expression as the underlying factor of tissue divergence.

Although the mechanism that translates *Gdf5* expression dynamics to lineage divergence is yet to be deciphered, we identify two important parameters, the duration and time of onset of *Gdf5* expression, whose combination may determine lineage divergence ([Figure 5](#fig5){ref-type="fig"}). For example, cells that would eventually contribute to the epiphysis lost *Gdf5* expression, whereas cells that contributed to the meniscus and knee cruciate ligaments exhibited completely different dynamics and maintained *Gdf5* expression. Interestingly, articular cartilage was also found to express *Gdf5* continually. However, the recruitment of most of these cells started 1 day later than in the ligaments and menisci. This differential behavior can serve as a mechanism by which cells contributing to different joint tissues acquire their fate ([Figure 5](#fig5){ref-type="fig"}). This notion is supported by previous studies showing that *Gdf5* is essential for the development of intra-articular ligaments ([@bib9]), which were absent in *bp* mice, and that human mesenchymal stem cells (hMSCs) and murine adipose tissue-derived mesenchymal stem cells treated with GDF5 showed an elevation in tendon-specific markers such as scleraxis (*Scx*) ([@bib26], [@bib38]). An example for the onset of *Gdf5* expression as a cue for lineage divergence is the case of the metacarpophalangeal joint capsule, where the contributing cells start to express this gene only on E13.5.

The influx of new cells and the dynamic behavior of joint-forming, *Gdf5*-expressing cells may provide flexibility both in development and during evolution. Various joint structures support specific functions and mechanical needs. Development through multiple steps, some of which are lineage-specific, may enable faster and more efficient changes in joint structure by manipulating only a subpopulation of joint-forming cells.

A key question that remains to be solved is the source of the recruited cells. Previous studies have shown that all joint structures originate from matrilin 1-negative ([@bib12]) and *Sox9*-positive cells ([@bib33]). Other works indicate that cells are recruited into the developing joint ([@bib13], [@bib17], [@bib25], [@bib28]). Our study identifies a population of *Sox9*-positive, *Col2a1*, *Gdf5*-negative cells outside of the joint area that may serve as an external source. However, this supposition is yet to be conclusively confirmed. Another possibility is an internal origin correlating to the *Sox9*-positive, *Col2a1*, *Gdf5*-negative cells we observed in the interzone. However, we believe that there are several indications for recruitment from an outside source.

First, the *Gdf5* expression domain is initially very broad, occupying the entire interzone and leaving no room for *Sox9*+, *Gdf5*−, *Col2a1*− cells to contribute to the *Gdf5*-expressing population. Moreover, as we demonstrate, the CreER^T2^ system is highly efficient and is thus likely to mark the majority of *Gdf5*-positive interzone cells. Nonetheless, we cannot rule out the possibility that a unique subpopulation of unlabeled *Gdf5*-positive interzone cells contributes to joint growth and, as an internal source, to cell recruitment. Last, we demonstrate a clear decrease in the number of *Sox9+, Gdf5*− cells flanking the forming joint during development, supporting the argument that this population is the source for joint cells.

Interestingly, a recent study by [@bib28] suggests that articular cartilage originates from proliferating chondrocytes, proposing another possible source outside of the interzone. However, because a different system was used in that study, the *Col2a1-CreER*^T2^ mouse, the exact spatial and temporal relationships between the process identified by [@bib28] and the one described here are yet to be determined. A plausible explanation for the apparent differences is that both these processes contribute to joint formation in varying proportions. Thus, examination of different joints at different time points may yield inconsistent results.

From a medical perspective, joints exhibit a very limited capacity for regeneration ([@bib15], [@bib30]). Our results suggest that, to improve regeneration, it may be necessary to search for a mechanism that can enhance or activate cell recruitment.

In conclusion, our findings indicate that joints do not form from a single pool of early-specified *Gdf5*-positive cells but, rather, through a continuous influx of *Gdf5*-positive cells, hence the term influx model. Moreover, we show highly dynamic spatiotemporal patterns of *Gdf5* expression by interzone cells, which may serve as differentiation cues. An additional differentiation signal may be the temporal specification of cells that will contribute differentially to the various tissues of the mature joint, thus facilitating lineage divergence of *Gdf5*-positive cells.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

All experiments involving mice were approved by the Institutional Animal Care and Use Committee (IACUC) of the Weizmann Institute. *Rosa26-tdTomato* mice (B6;129S6-*Gt(ROSA)26Sortm9(CAG-tdTomato)Hze*/J) have been described previously ([@bib21], [@bib33]). The generation of *Gdf5-CreER* knockin mice is described in the Supplemental Experimental Procedures. To create *Gdf5-CreER, Rosa26-tdTomato* mice, floxed *Rosa26-tdTomato* mice were mated with *Gdf5-CreER* mice.

For harvesting of embryos, timed pregnant females were sacrificed by cervical dislocation.

Tamoxifen Administration {#sec4.2}
------------------------

Pregnant female mice were administered 0.12--0.18 mg/g tamoxifen/body weight in corn oil by oral gavage.

Cryosectioning {#sec4.3}
--------------

Embryos were fixed in 4% paraformaldehyde (PFA)/PBS for 3 hr at 4**°**C, washed overnight in 30% sucrose/PBS at 4**°**C, embedded in O.C.T., and sectioned at a thickness of 10 μm.

Immunofluorescent Staining {#sec4.4}
--------------------------

For paraffin section immunofluorescence, embryos were fixed overnight in 4% PFA/PBS, dehydrated to 100% ethanol, embedded in paraffin, and sectioned at a thickness of 7 μm. 10 mM sodium citrate (pH 6.0) was used for antigen retrieval. Slides were incubated overnight at 4**°**C with primary antibody anti-BrdU (AbD) diluted 1:200 and with biotinylated anti-RFP (Abcam) diluted 1:100 in blocking solution to visualize tdTomato. For COL2A1 and tdTomato double immunostaining, after staining for tdTomato, slides were subjected to additional digestion by Proteinase K (Sigma). Slides were incubated overnight at 4**°**C with the primary antibody anti-COL2 (Developmental Studies Hybridoma Bank \[DSHB\], University of Iowa) 1:50 in blocking solution.

Following fluorescence ISH, slides were incubated overnight at 4**°**C with the primary antibody anti-COL2 (DSHB) 1:50 in blocking solution or with anti-RFP (Abcam) diluted 1:100 in blocking solution to visualize tdTomato.

In Situ Hybridization {#sec4.5}
---------------------

Non-fluorescent ISH on paraffin sections was performed using a digoxigenin (DIG)-labeled probe for *Gdf5*. Double fluorescence ISH on paraffin sections was performed using fluorescein- and DIG-labeled probes. The extended protocol was described by [@bib31].

BrdU Administration {#sec4.6}
-------------------

Mice were injected intraperitoneally with 100 mg/kg of body weight BrdU labeling reagent (Sigma) and sacrificed 4 hr later. Forelimbs and hindlimbs were fixed in 4% PFA overnight at 4°C, dehydrated in ethanol, and embedded in paraffin.

Cell Count {#sec4.7}
----------

For calculation of the percentage of tdTomato-positive cells contributing to the articular cartilage, 10-μm thick cryosections were counterstained with DAPI. tdTomato-positive cells were manually counted at the distal femoral and humeral heads as well as at the articular cartilage area, identified histologically as the external four to five cell layers. The percentage was calculated for each photographed section and averaged first for each embryo and then for each analyzed stage of tamoxifen administration.

To test the proliferation of tdTomato-positive cells, tdTomato-positive and tdTomato-BrdU-double positive cells were counted manually in BrdU-, RFP-, and DAPI-stained paraffin sections. In both experiments, 3-12 sections of each joint from each embryo were used, and three embryos from different litters were analyzed for each embryonic stage. Sections were photographed and examined by an LSM 710 or 780 confocal microscope. Data are represented as mean ± SD.

Co-localization Measurements {#sec4.8}
----------------------------

Section double ISH for *tdTomato* and *Gdf5* was imaged with an LSM 710 or 780 confocal microscope. The co-localization analysis was performed using the Imaris 8.2 colocalization module. For each analyzed picture, a region of interest covering the entire area of the knee joint containing *tdTomato*- and *Gdf5*-positive cells was defined and used for all measurements. Two to eleven sections of each joint from each embryo were used, and two to three embryos from two to three different litters were analyzed for each embryonic stage. The results represent all measured values ± SD.
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====================

Y.S., S.V., and S.K. conducted the experiments. E.Z. and Y.S. designed the study and wrote the manuscript.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S3Document S2. Article plus Supplemental Information

We thank N. Konstantin for expert editorial assistance. We thank Dr. Reinat Nevo for help with the co-localization analysis and all members of the E.Z. laboratory for advice and suggestions. This study was funded by the European Research Council (ERC; grant no. 310098), the Jeanne and Joseph Nissim Foundation for Life Sciences Research, the Y. Leon Benoziyo Institute for Molecular Medicine, Beth Rom-Rymer, the Estate of David Levinson, the Jaffe Bernard and Audrey Foundation, Georges Lustgarten, and the David and Fela Shapell Family Foundation.

Supplemental Information includes Supplemental Experimental Procedures and three figures and can be found with this article online at [http://dx.doi.org/10.1016/j.celrep.2016.05.055](10.1016/j.celrep.2016.05.055){#intref0010}.

![Limited Proliferation of *Gdf5*+ Lineage Cells Contradicts the Interzone Progenitor Hypothesis\
(A) Sections through the knee, elbow, and autopod of E11.5 embryos show *Gdf5* expression in various joints.\
(B) Pulse-chase lineage tracing experiment with a single dose of tamoxifen administered on E10.5 to mark approximately the same cell populations shown in (A). Sections through E18.5 *Gdf5-CreER*, *Rosa26-tdTomato* embryo knee, elbow, and metacarpophalangeal joints show that *tdTomato*-positive cells do not occupy most of the joint area.\
(C) Left: illustration of the predicted outcome of multiple tamoxifen (Tm) administrations according to the influx model. Right: sections through E18.5 forelimb and hindlimb following repeated pulsing on E11.5, E13.5, and E15.5 show numerous *tdTomato*-positive cells at the knee (top left), elbow (top right), metacarpophalangeal (bottom left), and humeroscapular (bottom right) joints, consistent with the model.\
(D) Pulse-chase experiment with a single dose of tamoxifen administered on E11.5. Shown is immunofluorescent staining for BrdU (green) and tdTomato (red) on sections through elbow and knee joints on E13.5, E15.5, and E18.5 (arrows indicate double-labeled cells).\
(E) Quantification of the percentage of proliferating descendants of *Gdf5*-expressing cells on E13.5, E15.5, and E18.5.\
Scale bars represent 100 μm.](gr1){#fig1}

![Joint Development Involves Continuous Steps of Recruitment and Specification of New Cells\
(A) Immunofluorescent staining (green) and gene expression (red) of the tdTomato reporter demonstrate reliable detection of the reporter by ISH.\
(B) Double ISH for *Gdf5* (green) and *tdTomato* (red) genes on E12.5--E14.5, following administration of a single tamoxifen dose on E11.5--E13.5, respectively, shows that almost the entire *Gdf5*-expressing population was genetically marked (arrows indicate *tdTomato-*positive, *Gdf5*-negative cells).\
(C) Quantification of the percentage of *Gdf5*, *tdTomato* double-positive cells from all *Gdf5-*positive cells.\
(D) Quantification of the percentage of *tdTomato*-positive, *Gdf5*-negative cells from all *tdTomato*-positive cells.\
(E) Analysis of *Gdf5* (green) and *tdTomato* (red) expression on E13.5--E15.5, following tamoxifen administration on E11.5, shows dynamic expression patterns and the existence of newly recruited cells that express only *Gdf5* (arrows).\
(F) Analysis of *Gdf5* and *tdTomato* gene expression in E15.5 knee joints following a single tamoxifen administration on E10.5--E13.5 shows that recruitment is a continuous process (newly recruited cells are indicated by arrows).\
(G) Analysis of tdTomato (red) and COL2A1 (white) protein localization on an E15.5 knee joint following a single tamoxifen administration on E11.5--E13.5. Bottom: magnifications of the boxed areas at the top. Curved lines demarcate the epiphyseal domains where contribution of tdTomato-positive cells is seen.\
Scale bars represent 50 μm (A) and 100 μm (B--G).](gr2){#fig2}

![Differential Contribution of Cell Subpopulations to Various Joint Tissues\
Pulse-chase experiments using *Gdf5-CreER*, *Rosa26-tdTomato* mice were performed.\
(A, C, D, and F) Tamoxifen was administered at various stages between E10.5 and E16.5. Examination on E18.5 shows the contribution of different *Gdf5*-expressing pools to the developing knee (A and C), elbow (D), and metacarpophalangeal (F) joints.\
(B and E) Quantification of the percentage of *tdTomato*-positive cells contributing to articular cartilage from all labeled cells at the distal femur (B) and distal humerus (E).\
(G and H) Analysis of *Gdf5* (green) and *tdTomato* (red) expression in E15.5 medial knee sections through the meniscus (top) and mid-sagittal sections through the cruciate ligaments (bottom) following pulsing on E11.5 (G) and E12.5 (H) shows a substantial overlap in expression domains in the ligaments compared with the meniscus (dashed lines demarcate the femur epiphysis).\
Scale bars represent 100 μm.](gr3){#fig3}

![Gene Expression Dynamics Suggests that Influx of Sox9-Positive Cells Contributes to Joint Formation\
(A--F) *Gdf5* and *Sox9* double ISH and COL2A1 immunofluorescent staining on sections through E12--E15.5 knee joints. Arrows indicate a population of *Sox9*-positive *Gdf5*, COL2A1-negative cells outside (solid arrows) and inside (dashed arrows) of the interzone. Scale bars represent 100 μm.](gr4){#fig4}

![A Revised Model for Joint Development\
Joint development involves constant specification of new *Gdf5*-positive cells from *Sox9*-expressing chondroprogenitors.\
(A) These cells exhibit a highly dynamic behavior. Thus, some early-specified cells (yellow) will quickly lose *Gdf5* expression and contribute to the growing epiphyses more than later-recruited cells (orange and red).\
(B) In contrast, the constant influx of specified cells that are destined to contribute to the intra-articular ligaments will maintain *Gdf5* expression and their localization to the developing joint site.](gr5){#fig5}
